These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10210518)

  • 21. Facilitatory effect of the dopamine D4 receptor agonist PD168,077 on memory consolidation of an inhibitory avoidance learned response in C57BL/6J mice.
    Bernaerts P; Tirelli E
    Behav Brain Res; 2003 Jun; 142(1-2):41-52. PubMed ID: 12798264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Memory-improving actions of glucose: involvement of a central cholinergic muscarinic mechanism.
    Kopf SR; Baratti CM
    Behav Neural Biol; 1994 Nov; 62(3):237-43. PubMed ID: 7857246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strain-dependent effects of post-training dopamine receptor agonists and antagonists on memory storage in mice.
    Cestari V; Castellano C; Cabib S; Puglisi-Allegra S
    Behav Neural Biol; 1992 Jul; 58(1):58-63. PubMed ID: 1358055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine induces inhibitory effects on the circular muscle contractility of mouse distal colon via D1- and D2-like receptors.
    Auteri M; Zizzo MG; Amato A; Serio R
    J Physiol Biochem; 2016 Aug; 73(3):395-404. PubMed ID: 28600746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strain-dependent effects of cocaine on memory storage improvement induced by post-training physostigmine.
    Castellano C; Zocchi A; Cabib S; Puglisi-Allegra S
    Psychopharmacology (Berl); 1996 Feb; 123(4):340-5. PubMed ID: 8867873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological evidence of muscarinic-cholinergic sensitization following chronic stress.
    Orsini C; Castellano C; Cabib S
    Psychopharmacology (Berl); 2001 May; 155(2):144-7. PubMed ID: 11401002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxotremorine attenuates retrograde amnesia induced by post-training administration of the GABAergic agonists muscimol and baclofen.
    Castellano C; McGaugh JL
    Behav Neural Biol; 1991 Jul; 56(1):25-31. PubMed ID: 1651077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The full D1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: regulation of D1/D2 interactions by muscarinic receptors.
    Wang JQ; McGinty JF
    J Pharmacol Exp Ther; 1997 May; 281(2):972-82. PubMed ID: 9152408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between the NMDA competitive antagonist CPP and the dopaminergic system in one-trial inhibitory avoidance in C57BL/6 mice.
    Mele A; Castellano C; Cestari V; Oliverio A
    Neurobiol Learn Mem; 1995 Mar; 63(2):143-8. PubMed ID: 7663887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological characterization of the D1- and D2-like dopamine receptors from the brain of the leopard frog, Rana pipiens.
    Chu J; Wilczynski W; Wilcox RE
    Brain Behav Evol; 2001 Jun; 57(6):328-42. PubMed ID: 11713387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotypic differences in brain dopamine receptor function in the DBA/2J and C57BL/6J inbred mouse strains.
    Ng GY; O'Dowd BF; George SR
    Eur J Pharmacol; 1994 Nov; 269(3):349-64. PubMed ID: 7895774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression.
    Keefe KA; Gerfen CR
    Neuroscience; 1995 Jun; 66(4):903-13. PubMed ID: 7651617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of dopamine on GABA release in striatum: evidence for D1-D2 interactions and non-synaptic influences.
    Harsing LG; Zigmond MJ
    Neuroscience; 1997 Mar; 77(2):419-29. PubMed ID: 9472401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of dopamine D1/D2 receptors on harmane-induced amnesia in the step-down passive avoidance test.
    Nasehi M; Piri M; Nouri M; Farzin D; Nayer-Nouri T; Zarrindast MR
    Eur J Pharmacol; 2010 May; 634(1-3):77-83. PubMed ID: 20188725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible interaction between central cholinergic muscarinic and opioid peptidergic systems during memory consolidation in mice.
    Baratti CM; Introini IB; Huygens P
    Behav Neural Biol; 1984 Mar; 40(2):155-69. PubMed ID: 6732709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholinergic-dopaminergic interactions in cognitive performance.
    Levin ED; McGurk SR; Rose JE; Butcher LL
    Behav Neural Biol; 1990 Nov; 54(3):271-99. PubMed ID: 2078161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
    LaHoste GJ; Marshall JF
    Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of dopamine D1-like and D2-like antagonists on cocaine discrimination in muscarinic receptor knockout mice.
    Thomsen M; Caine SB
    Eur J Pharmacol; 2016 Apr; 776():71-80. PubMed ID: 26874213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of central administration of dopaminergic and cholinergic agents on morphine-induced amnesia in morphine-sensitized mice.
    Zarrindast MR; Farahmandfar M; Rostami P; Rezayof A
    J Psychopharmacol; 2006 Jan; 20(1):59-66. PubMed ID: 16174677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.